Cargando…
Potential role of Chinese medicine nanoparticles to treat coronary artery disease
Coronary artery disease (CAD) is a leading cause of death worldwide, while conventional treatments such as percutaneous coronary intervention (PCI) have limitations. This review aims to explore the potential of nanoparticles loaded with Chinese medicine in the treatment of CAD. We conducted a compre...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559060/ https://www.ncbi.nlm.nih.gov/pubmed/37809499 http://dx.doi.org/10.1016/j.heliyon.2023.e19766 |
_version_ | 1785117415450869760 |
---|---|
author | Yang, Rongyuan Gu, Yingming Qin, Jinying Liu, Qingqing Liu, Qing |
author_facet | Yang, Rongyuan Gu, Yingming Qin, Jinying Liu, Qingqing Liu, Qing |
author_sort | Yang, Rongyuan |
collection | PubMed |
description | Coronary artery disease (CAD) is a leading cause of death worldwide, while conventional treatments such as percutaneous coronary intervention (PCI) have limitations. This review aims to explore the potential of nanoparticles loaded with Chinese medicine in the treatment of CAD. We conducted a comprehensive literature search to summarize the characteristics of nanovehicle systems, targeting strategies, and administration methods of various nanoparticles containing Chinese medicine for CAD treatment. Nanoparticle-based drug delivery systems, capable of delivering Chinese medicine, offer several advantages, including high targeting efficiency, prolonged half-life, and low systemic toxicity, making them promising for CAD treatment. Overall, nanoparticles containing Chinese medicine present a promising approach for the treatment of CAD. |
format | Online Article Text |
id | pubmed-10559060 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-105590602023-10-08 Potential role of Chinese medicine nanoparticles to treat coronary artery disease Yang, Rongyuan Gu, Yingming Qin, Jinying Liu, Qingqing Liu, Qing Heliyon Review Article Coronary artery disease (CAD) is a leading cause of death worldwide, while conventional treatments such as percutaneous coronary intervention (PCI) have limitations. This review aims to explore the potential of nanoparticles loaded with Chinese medicine in the treatment of CAD. We conducted a comprehensive literature search to summarize the characteristics of nanovehicle systems, targeting strategies, and administration methods of various nanoparticles containing Chinese medicine for CAD treatment. Nanoparticle-based drug delivery systems, capable of delivering Chinese medicine, offer several advantages, including high targeting efficiency, prolonged half-life, and low systemic toxicity, making them promising for CAD treatment. Overall, nanoparticles containing Chinese medicine present a promising approach for the treatment of CAD. Elsevier 2023-09-01 /pmc/articles/PMC10559060/ /pubmed/37809499 http://dx.doi.org/10.1016/j.heliyon.2023.e19766 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Article Yang, Rongyuan Gu, Yingming Qin, Jinying Liu, Qingqing Liu, Qing Potential role of Chinese medicine nanoparticles to treat coronary artery disease |
title | Potential role of Chinese medicine nanoparticles to treat coronary artery disease |
title_full | Potential role of Chinese medicine nanoparticles to treat coronary artery disease |
title_fullStr | Potential role of Chinese medicine nanoparticles to treat coronary artery disease |
title_full_unstemmed | Potential role of Chinese medicine nanoparticles to treat coronary artery disease |
title_short | Potential role of Chinese medicine nanoparticles to treat coronary artery disease |
title_sort | potential role of chinese medicine nanoparticles to treat coronary artery disease |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559060/ https://www.ncbi.nlm.nih.gov/pubmed/37809499 http://dx.doi.org/10.1016/j.heliyon.2023.e19766 |
work_keys_str_mv | AT yangrongyuan potentialroleofchinesemedicinenanoparticlestotreatcoronaryarterydisease AT guyingming potentialroleofchinesemedicinenanoparticlestotreatcoronaryarterydisease AT qinjinying potentialroleofchinesemedicinenanoparticlestotreatcoronaryarterydisease AT liuqingqing potentialroleofchinesemedicinenanoparticlestotreatcoronaryarterydisease AT liuqing potentialroleofchinesemedicinenanoparticlestotreatcoronaryarterydisease |